Comprehensive Analysis of the Tumor Ablation Therapy Devices Market 2025-2034: Growth Rates, Trends, and Future Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What fueled the previous growth in the tumor ablation therapy devices market?
Recent years have seen swift expansion in the market size of tumor ablation therapy devices. The market, valued at $0.72 billion in 2024, is projected to increase to $0.83 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 15.0%. Factors contributing to this growth in the historic period include risings incidences of cancer, technological progress, an aging demographic, and the prevalence of minimally invasive procedures.
What will be the tumor ablation therapy devices market size in the future?
In the forthcoming years, fast-paced growth is projected for the tumor ablation therapy devices market. Its valuation is foreseen to reach $1.44 billion by 2029, growing at a compound annual growth rate (CAGR) of 14.8%. Factors contributing to this expected growth include personalized medical treatment, combined therapy methods, use of artificial intelligence and image-guided ablation, the prevalence of telemedicine and virtual consultations, and ongoing training and education initiatives. Notable trends for the prediction period encompass enhancements in ablation technologies, imaging guidance, assistance from robotic and navigation systems, integration with immuno-oncology, and increased use of percutaneous and image-guided ablation.
Get your tumor ablation therapy devices market report here!
https://www.thebusinessresearchcompany.com/sample.aspx?id=3351&type=smp
What main drivers are fueling expansion in the tumor ablation therapy devices market?
The rise in cancer cases globally is a key driver fuelling the expansion of the tumor ablation therapy devices market. Cancer is reckoned as the second leading cause of mortality globally, with 1 in every 6 deaths being attributed to cancer. Tumor ablation, a technique that is minimally invasive, is prevalently employed in dealing with lung, liver, kidney, and bone mutations. For instance, in 2023, per the statistics by American Cancer Society Inc., a non-profit health organization based in the US, approximately 1,958,310 new cancer cases are projected to be identified in the US. This represents growth from over 1,918,030 new cases diagnosed in 2022. This treatment method is effective for those who haven’t responded well to chemotherapy or radiation therapy, thereby cementing the growth of the tumor ablation therapy devices market.
What key areas define the segmentation of the global tumor ablation therapy devices market?
The tumor ablation therapy devices market covered in this report is segmented –
1) By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, Other Technologies
2) By Treatment: Surgical, Laparoscopic, Percutaneous
3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Applications
4) By End User: Hospitals, Oncology Clinics, Other End Users
Subsegments:
1) By Radiofrequency Ablation (RFA): Monopolar RFA Devices, Bipolar RFA Devices
2) By Microwave Ablation: High-frequency Microwave Devices, Low-frequency Microwave Devices
3) By Cryoablation: Liquid Nitrogen-based Devices, Argon Gas-based Devices
4) By Irreversible Electroporation Ablation (IRE): NanoKnife Ablation Systems, High-voltage Pulse Generators
5) By Other Technologies: Laser Ablation Devices, Ultrasound-guided High-intensity Focused Ultrasound (HIFU), Chemical Ablation Techniques
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3351&type=smp
Who are the dominant players expanding their reach in the tumor ablation therapy devices market?
Major companies operating in the tumor ablation therapy devices market include Galil Medical Inc., Misonix Inc., HealthTronics Inc., AngioDynamics Inc., Boston Scientific Corporation, Medtronic plc, EDAP TMS S.A., NeuWave Medical Inc., BVM Medical Limited, Erbe Elektromedizin GmbH, AtriCure Inc., Theraclion, INTIO Inc., BIOTRONIK SE & Co. KG, Olympus Corporation, Stryker Corporation, Merit Medical Systems Inc., Insightec Ltd., Terumo Corporation, Smith & Nephew plc, Monteris Medical Corporation, IceCure Medical Ltd., Profound Medical Inc., Alpinion Medical Systems Co. Ltd., Sonacare Medical, Hologic Inc., Endocare Inc., Integra LifeSciences Corporation, Bovie Medical Corporation
How are evolving market trends shaping tumor ablation therapy devices Strategies?
Leading organizations engaged in the production of tumor ablation therapy devices are pivoting towards technological evolution to ensure quicker procedures, enhanced safety, reduced radiation exposure, quicker learning curves, and better end results. One such innovation is the microwave ablation system, NEUWAVE, launched by J&J medicals. This revolutionary device is the first of its kind to introduce electrodes into cancer cells, thereby escalating their surrounding temperatures to eradicate them effectively. An example of such progression is provided by Compal Electronics, with the unveiling of AblatePal in April 2023. Based out of Taiwan, this electronics manufacturing firm brought forward this novel radiofrequency ablation (RFA) system. It facilitates percutaneous, intraoperative coagulation, and ablation of soft tissue, thus covering a spectrum from partial to complete treatment of non-resectable liver lesions. Functioning by using the heat produced from electrical resistance while the current traverses through the tissue, the system successfully eliminates the targeted tissue. It is mainly used in therapeutic medical devices and has been crafted to manage an array of medical conditions, cancer being the notable one among them.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3351
Which regions are emerging as leaders in the tumor ablation therapy devices market?
North America was the largest region in the tumor ablation therapy devices market in 2023. Asia-Pacific was the second largest region in the tumor ablation therapy devices market. The regions covered in the tumor ablation therapy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Cancer Diagnostics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report
Bladder Cancer Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/bladder-cancer-drugs-global-market-report
Interventional Oncology Devices Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
